Document Detail


Prognostic value of screening for irregular antibodies late in pregnancy in rhesus positive women.
MedLine Citation:
PMID:  12027813     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
BACKGROUND: To evaluate the prognostic value of screening for irregular antibodies late in pregnancy (third trimester) in rhesus positive women. Only those cases where irregular antibodies have not previously been demonstrated during routine screening in the first trimester with regard to clinically relevant complications in the newborn, were studied. MATERIALS AND METHODS: All women living in Frederiksborg county and giving birth in 1996 (n = 4216) were assessed for inclusion in the study. This was done by gathering the files at the Hillerød and Hørsholm Hospitals' blood banks for antibody test results. Six hundred women were excluded because of the lack of either the rhesus type or the late antibody test. RESULTS: Of the 3616 women, 3046 were rhesus positive, and 3012 of these had a negative first trimester screen test. Fifteen of the 3012 women later developed irregular antibodies in the third trimester, and were included in the study. This corresponds to only 0.5%, and none of these cases entailed perinatal complications for the mother or the child. CONCLUSION: Routine screening of rhesus positive pregnant women in the third trimester is not rational from a cost-benefit perspective, if the only purpose is to prevent hemolytic disease of the newborn.
Authors:
Anita S Andersen; Lisbeth Praetorius; Henrik L Jørgensen; Kirsten Lylloff; Kim T Larsen
Related Documents :
7497163 - Screening for breast cancer in women aged under 50: mode of detection, incidence, fatal...
19058073 - Perceptions of knowledge, beliefs, and barriers to colorectal cancer screening.
8581793 - Obesity in europe.
Publication Detail:
Type:  Evaluation Studies; Journal Article    
Journal Detail:
Title:  Acta obstetricia et gynecologica Scandinavica     Volume:  81     ISSN:  0001-6349     ISO Abbreviation:  Acta Obstet Gynecol Scand     Publication Date:  2002 May 
Date Detail:
Created Date:  2002-05-24     Completed Date:  2002-06-20     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  0370343     Medline TA:  Acta Obstet Gynecol Scand     Country:  Denmark    
Other Details:
Languages:  eng     Pagination:  407-11     Citation Subset:  IM    
Affiliation:
Department of Obstetrics and Gynecology and Clinical Immunology, Hillerød Hospital, Denmark.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Antibodies / analysis*
Blood Grouping and Crossmatching / methods*
Denmark / epidemiology
Erythroblastosis, Fetal / blood*,  diagnosis,  epidemiology*
Female
Humans
Infant, Newborn
Predictive Value of Tests
Pregnancy
Pregnancy Trimester, Third
Prenatal Diagnosis / standards*
Registries
Rh-Hr Blood-Group System*
Chemical
Reg. No./Substance:
0/Antibodies; 0/Rh-Hr Blood-Group System

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Disappearance of human chorionic gonadotropin after cesarean section with regard to fetal sex.
Next Document:  Individual risk assessment of thrombosis in pregnancy.